Methods for treating malaria by administering an antibody that specifically binds angiopoietin-2 (ang-2)
US9371379B2 · kind B2 · utility
1Cited by
15References
8Claims
0Family size
Inventors
Key dates
| Filing date | Dec 19, 2013 |
| Grant date | Jun 21, 2016 |
| Priority date | — |
| Expiry date | May 14, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for treating malaria by administering to a patient in need thereof a pharmaceutical composition comprising an antibody that specifically binds human angiopoietin-2 (Ang-2).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.